SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Today, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammation lead drug development, as well as the development of E…
SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Today, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammation lead drug development, as well as the development of ELISA kits and Multiplex analyses.
In the last year, we have continued our diversification and through partnerships with several companies, our product line now includes specific enzymes, specific kinase activity analysis and in vivo cancer models.
SBH Sciences has been an innovator in the biotechnology field for 17 years, working with over 120 biotechnology and diagnostic companies. Our diverse diagnostic and drug development activities are fueled by unique products and preclinical services in the cytokine, anti-cancer, and anti-inflammation areas.
We provide exemplary customer service and are committed to open communication and on-time-delivery. We support innovation by providing incubator-style support to startup companies and entrepreneur scientists. SBH Sciences is a stimulating workplace and we place an importance on personal growth for our dedicated employees.
SBH Sciences' slogan is "Experience - Innovation - Persistence" and we demonstrate this by supporting the biotechnology industry while maintaining the highest ethical standards.
Team (1)
Sectors SBH Sciences serves:
Life Sciences
Join Axial's Private M&A Platform
SBH Sciences connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
